Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BIOCLINICA
(NQ:
BIOC
)
7.280
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EDT, Mar 13, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
All news about BIOCLINICA
< Previous
1
2
3
4
5
6
7
Next >
BioClinica and CoreLab Partners Are One
March 14, 2013
from
Business Wire News Releases
BioClinica, Inc. and JLL Partners, Inc. Announce Successful Completion of Tender Offer
March 12, 2013
from
Business Wire News Releases
Medtentia International and clinicalprojects international Tap BioClinica for Express EDC, Data Management, and Centralized Imaging Reads
March 04, 2013
from
Business Wire News Releases
BioClinica, Inc. and JLL Partners, Inc. Announce Early Termination of Hart-Scott-Rodino Act Waiting Period
February 21, 2013
from
Business Wire News Releases
BioClinica Inc (NASDAQ:BIOC) Investor Files Lawsuit to Halt Acquisition Attempt by JLL Partners
February 13, 2013
San Diego, CA -- (SBWIRE) -- 02/13/2013 -- An investor in shares of BioClinica Inc (NASDAQ:BIOC) filed a lawsuit to halt the proposed takeover of BioClinica Inc by JLL Partners, Inc at $7.25 per...
Read More
from
SBWire - Latest Press Releases
JLL Partners Begins $7.25/Share Tender for BioClinica (BIOC)
February 11, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8077229 for the full story.
Read More
from
StreetInsider.com News Articles
Affiliate of JLL Partners Commences Tender Offer for BioClinica at $7.25/Share
February 11, 2013
BioClinica®, Inc. (NASDAQ: BIOC ), a leading global provider of clinical trial management solutions and JLL Partners, Inc. (“JLL”), a leading private equity investment firm, announced today that BC...
Read More
category
Benzinga
,
BIOC
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Cash Tender Offer to Acquire BioClinica, Inc. at $7.25 Per Share Commenced by an Affiliate of JLL Partners, Inc.
February 11, 2013
from
Business Wire News Releases
Bioclinica, Inc. (BIOC) Tops Q4 EPS by 1c
February 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8063513 for the full story.
Read More
from
StreetInsider.com News Articles
BioClinica Announces Fourth Quarter and Full Year 2012 Financial Results
February 06, 2013
from
Business Wire News Releases
BioClinica Inc (NASDAQ:BIOC) Investor Alert: Investigation of Takeover Offer by JLL Partners, Inc
February 04, 2013
San Diego, CA -- (SBWIRE) -- 02/04/2013 -- An investigation on behalf of investors in BioClinica Inc (NASDAQ:BIOC) shares was announced concerning whether the offer by JLL Partners, Inc to acquire...
Read More
from
SBWire - Latest Press Releases
BioClinica to Release Fourth Quarter and Year-End 2012 Financial Results on February 6, 2013
February 04, 2013
from
Business Wire News Releases
Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of BioClinica, Inc. (BIOC)
February 01, 2013
from
Business Wire News Releases
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.
February 01, 2013
from
PR Newswire
Law Firm Brower Piven Announces Investigation of BioClinica, Inc.
January 31, 2013
from
Business Wire News Releases
Rigrodsky & Long, P.A. Announces Investigation Of BioClinica, Inc. Buyout
January 31, 2013
from
Business Wire News Releases
Acquisition of BioClinica, Inc. by JLL Partners, Inc. May Not Be in BioClinica, Inc. Shareholders' Best Interests
January 31, 2013
from
PR Newswire
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.
January 31, 2013
from
Business Wire News Releases
Ryan & Maniskas, LLP Announces Investigation of BioClinica, Inc.
January 31, 2013
from
PR Newswire
Hot Stocks of the Day (ABIO, GNBT, ALVR, BIOC, CPNO)
January 31, 2013
Lakeway, TX -- (SBWIRE) -- 01/31/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Hot Trending Stocks in Focus: KERX, BSX, BIOC, SFI, NYMT
January 31, 2013
Scottsdale, AZ -- (SBWIRE) -- 01/31/2013 -- Universal pennystocks.com focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny...
Read More
from
SBWire - Latest Press Releases
UPDATE: Benchmark Downgrades BioClinica to Hold Following Sale Agreement
January 31, 2013
Benchmark downgraded BioClinica, Inc (NASDAQ: BIOC ) from Buy to Hold and maintained a $7.25 price target. Benchmark said, "BioClinica announced it has entered into a definitive agreement with the...
Read More
category
Benzinga
,
BIOC
,
Benchmark
, and 3 more.
from
Latest Articles from Benzinga.com
Law Office of Brodsky & Smith, LLC Announces Investigation of BioClinica, Inc.
January 30, 2013
from
PR Newswire
Benzinga's M&A Chatter for Wednesday January 30, 2013
January 30, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday January 30, 2013: Hearing Endo Health in Talks with Potential Buyers The Rumor:Shares of Endo Health...
Read More
category
Benzinga
,
ALVR
,
Movers
, and 17 more.
from
Latest Articles from Benzinga.com
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of BioClinica, Inc. Shareholders
January 30, 2013
from
Business Wire News Releases
WeissLaw LLP Investigates BioClinica, Inc. Acquisition
January 30, 2013
from
Business Wire News Releases
JLL Partners To Buy BioClinica
January 30, 2013
JLL Partners will pay a premium of approximately $123 million in cash to acquire BioClinica Inc. (Nasdaq: BIOC) lifting the stock price $1.17 to close at $7.21....
Read More
from
MarketMinute.com Stock News
Micro Cap Stocks Alert (BIOC, GEVO, PVA, NLNK, XOMA)
January 30, 2013
Houston, TX -- (SBWIRE) -- 01/30/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com...
Read More
from
SBWire - Latest Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of BioClinica Inc. - BIOC
January 30, 2013
from
PR Newswire
Finkelstein Thompson LLP Announces Investigation of BioClinica, Inc.
January 30, 2013
from
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here